Alumis ALMS
NASDAQ ALMS
$6.40 -0.15 (-2.29%)
At close: Nov 10, 2026 · 4:00 PM EST

Alumis (ALMS) EBIT (2023 - 2026)

Updated

Alumis (ALMS) posted EBIT of -$148.86 million for Q2 2026, compared with -$140.54 million a year earlier.

Analysis

Alumis (ALMS) EBIT (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Alumis was -$501.13 million; for FY2025, it was -$453.8 million.

  • In prior years, Alumis' EBIT was -$300.75 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly EBIT in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.27 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.47 Bn
10 Alumis 796.45 Mn -915.01 Mn - -148.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Mar 31, 2026 -98.41 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn
API Access

Alumis EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ALMS&period=max&api_key=YOUR_API_KEY